Header cover image

Taiwanese (TAIEX) Life Sciences Industry Analysis

UpdatedJan 26, 2022
DataAggregated Company Financials
  • 7D-3.8%
  • 3M-11.0%
  • 1Y104.5%
  • YTD-4.9%

Over the last 7 days, the Life Sciences industry has dropped 3.8%, driven by declines from every company within the industry. This takes the industry's 12 month performance to a gain of 105%.

Industry Valuation and Performance

Has the Taiwanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 26 Jan 2022NT$35.9bNT$3.0b-NT$120,147,000.0034.6x
Fri, 24 Dec 2021NT$39.3bNT$3.0b-NT$120,147,000.0037.2x
Sun, 21 Nov 2021NT$30.4bNT$3.0b-NT$120,147,000.0035.9x
Tue, 19 Oct 2021NT$29.5bNT$2.3b-NT$631,150,000.0031.2x
Thu, 16 Sep 2021NT$35.4bNT$2.3b-NT$631,150,000.0032x
Sat, 14 Aug 2021NT$37.9bNT$2.3b-NT$631,150,000.0032.1x
Wed, 09 Jun 2021NT$35.3bNT$2.2b-NT$810,177,000.0028.4x
Tue, 02 Mar 2021NT$18.2bNT$2.2b-NT$912,568,000.0022.2x
Fri, 04 Dec 2020NT$16.1bNT$2.1b-NT$914,668,000.0022.5x
Mon, 07 Sep 2020NT$19.4bNT$1.8b-NT$1,161,248,000.0019.4x
Sun, 31 May 2020NT$16.5bNT$1.8b-NT$951,923,500.0020.9x
Wed, 04 Mar 2020NT$8.8bNT$1.7b-NT$771,818,000.0018.4x
Sat, 07 Dec 2019NT$7.8bNT$1.5b-NT$580,833,000.0018.4x
Tue, 10 Sep 2019NT$8.3bNT$1.6b-NT$347,403,000.0015.1x
Mon, 03 Jun 2019NT$9.1bNT$1.4b-NT$298,437,500.0022.1x
Thu, 07 Mar 2019NT$9.2bNT$1.4b-NT$240,203,000.0027.2x
PE Ratio


Total Market Cap: NT$8.5bTotal Earnings: -NT$240,203,000.00Total Revenue: NT$1.4b0%0%0%3 Year10 Year

Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 34.6x which is higher than its 3-year average PE of 23.5x. It appears they are confident that earnings will grow faster in the future than they have historically.

Past Earnings Growth: The earnings for companies in the Life Sciences industry have improved over the last three years, and revenues for these companies have grown 30% per year. This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Life Sciences industry?

Clinical Research and Equipment-3.80%

Industry PE: Investors are most optimistic about the Clinical Research and Equipment industry which is trading above its 3-year average PE ratio of 23.5x. This is likely because analysts are expecting annual earnings growth of 218%, which is higher than its past year's earnings growth of 19% per year.

Forecasted Growth: Analysts are most optimistic on the Clinical Research and Equipment industry, expecting annual earnings growth of 218% over the next 5 years. This is better than it's past earnings growth rate of 19% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall St‚ĄĘ
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News